Navigation Links
EPSScentral Responds to Pandemic Alert
Date:5/4/2009

ANNANDALE, Va., May 4 /PRNewswire/ -- EPSScentral LLC today announced its readiness to assist organizations in assembling, communicating, and implementing mitigation measures in the face of WHO's phase 5 classification of the Influenza A crisis. According to the WHO, phase 5 "...is a strong signal that a pandemic is imminent and that the time to finalize... mitigation measures is short."

(Logo: http://www.newscom.com/cgi-bin/prnh/20080701/DC26612LOGO)

A world leader in ensuring organizational competency and performance, EPSScentral, together with pandemic content experts and technology partners, developed a package to address pandemic planning needs. Commencing with the SARS and Avian Flu crises over the past two years, EPSScentral developed the solution as a component of its process improvement and standard operating procedures practices. According to President and CEO Gary J. Dickelman, "It is socially responsible at this time to communicate our rapid, innovative approach to mitigating business disruption caused by Influenza A, especially in these challenging economic times. Having a solid plan in place mitigates overreacting to pandemic press. It prevents unnecessary business disruption while addressing the health and safety of employees in measured and responsible ways."

EPSScentral's offering includes: A baseline, easily customizable pandemic contingency plan; a set of templates and tools for rapid localization and deployment; resources to jump-start customization; and access to additional expert knowledge as the Influenza A (aka H1N1, Swine Flu) or other pandemic scenarios evolve. A sample EPSScentral pandemic plan can be viewed at http://pandemic.epssnews.com.

EPSScentral LLC is known for quality solutions that provide explicit, accessible and usable end-to-end best-practice processes; accelerate development and rollout by up to 80%; decrease time-to-competency; and foster remarkable returns on investment. Since 2002, the Company has provided thought leadership and mission critical solutions that transform business and assure the organizational mission at the speed of work. A hallmark is EPSScentral's ability to reduce organizational complexity as processes grow and supporting technologies evolve. Using EPSScentral's approach, their large private and public sector clients typically realize a ten-fold return on investment. Contact Shirah Cohen, VP, at scohen@epsscentral.net, 703-851-0545 and visit http://www.epsscentral.net.


'/>"/>
SOURCE EPSScentral LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
2. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
3. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
4. Roche responds to announcement of IDEAL hepatitis C trial results
5. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
6. USAID Cooperates in Pandemic Preparedness Initiative
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
9. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
10. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
Breaking Medicine Technology:
(Date:8/19/2017)... , ... August 18, 2017 , ... ... Administration Reauthorization Act of 2017, legislation that provides for greater public access to ... moderate hearing loss to access OTC hearing aids without being seen by a ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... of breastfeeding mothers. These illustrations show the diversity of the breastfeeding mothers, ... a wide range of sizes. These illustrations are also available on tote bags, ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... ... More than 20,000 pairs of shoes made their way across the Atlantic ... that conjoined the passions of an NBA star, a Liberty University student, and an ... will save lives from the rampant infections transmitted through the soil. , AMERICAN SOLES ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
Breaking Medicine News(10 mins):